Evidence map›Paper›PMID 34349262›Full record

ArticleNature2021

Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A.

Chase A P Wood, Jinru Zhang, Deniz Aydin, Yan Xu, Benjamin J Andreone, Urs H Langen, Ron O Dror, Chenghua Gu, Liang Feng

Open access · greenAbstract read
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Structure and allostery in major facilitator superfamily symport mechanisms.Acta crystallographica. Section D, Structural biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. CD177Cellular and molecular life sciences : CMLS · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Molecular basis of prostaglandin ENature communications · 2025
    Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chase A P Wood *Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Jinru Zhang *Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Deniz AydinDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-2758-2480
Yan XuDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Benjamin J AndreoneDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Urs H LangenDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7412-276X
Ron O DrorDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-6418-2793
Chenghua GuDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4212-7232
Liang FengDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. liangf@stanford.edu.ORCID http://orcid.org/0000-0001-6171-2050
Stanford University · USHarvard University · USStanford Medicine · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Molecular Mechanisms of the Blood Brain Barrier Function and RegulationR35NS116820 · NINDS · HARVARD MEDICAL SCHOOL · PI CHENGHUA GU · 2020 to 2026
$7.0M
New tools for understanding the blood brain barrierDP1NS092473 · NINDS · HARVARD MEDICAL SCHOOL · PI GU, CHENGHUA · 2014 to 2018
$4.2M
Molecular Mechanism and Novel Therapeutic Strategy in Alzheimer's DiseaseDP2AG052940 · NIA · STANFORD UNIVERSITY · PI FENG, LIANG · 2015 to 2018
$2.6M
Howard Hughes Medical InstituteNIA NIH HHS DP2 AG052940NICHD NIH HHS P50 HD105351NINDS NIH HHS DP1 NS092473NINDS NIH HHS R35 NS116820
6 · The paper itself

Abstract

MFSD2A is a sodium-dependent lysophosphatidylcholine symporter that is responsible for the uptake of docosahexaenoic acid into the brain

Indexed as

Lipid MetabolismAnimalsBinding SitesBiological TransportBlood-Brain BarrierHEK293 CellsHumansMiceModels, MolecularMolecular Dynamics SimulationMutationProtein DomainsSodiumSymportersMFSD2A protein, humanMfsd2a protein, mouseSodiumSymporters

Identifiers

PMID34349262
PMCPMC8884080
OpenAlexW3187128303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.